TruBridge’s (TBRG) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of TruBridge (NASDAQ:TBRG) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $24.00 target price on the stock.

Separately, Royal Bank of Canada began coverage on shares of TruBridge in a research note on Thursday, March 28th. They set an outperform rating and a $13.00 price target for the company.

TruBridge Price Performance

Shares of TruBridge stock opened at $9.01 on Wednesday. The company has a quick ratio of 2.30, a current ratio of 2.31 and a debt-to-equity ratio of 1.05. TruBridge has a fifty-two week low of $7.55 and a fifty-two week high of $30.95. The firm has a market capitalization of $132.00 million, a price-to-earnings ratio of -2.86 and a beta of 0.63.

TruBridge (NASDAQ:TBRG) last issued its quarterly earnings results on Thursday, February 29th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. TruBridge had a negative net margin of 13.49% and a positive return on equity of 10.33%. The firm had revenue of $85.87 million during the quarter, compared to the consensus estimate of $83.50 million. As a group, analysts expect that TruBridge will post 0.99 EPS for the current fiscal year.

Insider Transactions at TruBridge

In related news, Director Glenn Tobin bought 10,500 shares of the company’s stock in a transaction dated Thursday, March 7th. The stock was acquired at an average cost of $8.04 per share, with a total value of $84,420.00. Following the acquisition, the director now owns 34,347 shares in the company, valued at approximately $276,149.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other TruBridge news, major shareholder L6 Holdings Inc. purchased 128,814 shares of the firm’s stock in a transaction that occurred on Thursday, March 14th. The shares were acquired at an average cost of $9.23 per share, for a total transaction of $1,188,953.22. Following the transaction, the insider now directly owns 1,322,814 shares in the company, valued at $12,209,573.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Glenn Tobin purchased 10,500 shares of the firm’s stock in a transaction that occurred on Thursday, March 7th. The shares were acquired at an average price of $8.04 per share, for a total transaction of $84,420.00. Following the completion of the transaction, the director now owns 34,347 shares in the company, valued at $276,149.88. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 364,858 shares of company stock valued at $3,473,199. Corporate insiders own 3.60% of the company’s stock.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.